Talk:Leukotriene antagonist

From Wikipedia, the free encyclopedia
Jump to: navigation, search
WikiProject Medicine (Rated Stub-class, Mid-importance)
WikiProject icon This article is within the scope of WikiProject Medicine, which recommends that this article follow the Manual of Style for medicine-related articles and use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.
Stub-Class article Stub  This article has been rated as Stub-Class on the project's quality scale.
 Mid  This article has been rated as Mid-importance on the project's importance scale.
 

diseases/problems?[edit]

Current, the article has this sentence:
"Leukotriene inhibitors (or modifiers), such as montelukast, zafirlukast and zileuton, are used to treat those diseases."
there is NO mention of "those diseases". There is also no listing of problems that leukasts are good for helping (like allergic rhinitis or astma)... --74.179.110.142 (talk) 14:02, 10 September 2010 (UTC)

mechanism of action[edit]

"inhibiting the synthetic pathway of leukotriene metabolism"
what does this mean? The MOA section is too details focused and misses the bigger picture.--74.179.110.142 (talk) 14:06, 10 September 2010 (UTC)